Article references (11 references )

  1. Chourrout P. La procalcitonine de la découverte à l'utilisation clinique. Med Nuc. 2008;32:132-137. Google Scholar

  2. Nijsten MW, Olinga P, The TH, De Vries EG et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med. 2000 Feb;28(2):458-61. PubMed | Google Scholar

  3. Kallel S, Abid M, Jarraya A, Abdenadher M et al. Cinétique et intérêt diagnostique et pronostique de la procalcitonine après chirurgie cardiaque. Ann Biol Clin (Paris). 2012 Oct 1; 70(5):567-80. Google Scholar

  4. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004 Feb 21;363(9409):600-7. PubMed | Google Scholar

  5. Simon L, Gauvin F, Amre DK, Saint-Louis P et al. Serum procalcitonin and C reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004 Jul 15;39(2):206-17. PubMed | Google Scholar

  6. Penel N, Fournier C, Clisant S, N'Guyen M. Causes of fever and value of C reactive protein and procalcitonin in differentiating infections from paraneoplastic fever. Support Care Cancer. 2004 Aug; 12(8):593-8. PubMed | Google Scholar

  7. Tulek B, Koylu H, Kanat F, Arslan U, et al. Serum C-reactive protein and procalcitonin levels in non small cell lung cancer patients. Wspolczesna Onkol. 2013;17(1): 68-72. Google Scholar

  8. Becker KL, Snider R, Silva OL, Moore CF. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer. Acta Endocrinol (Copenh). 1978 Sep;89(1):89-99. PubMed | Google Scholar

  9. Carsin H, Assicot M, Feger F, Roy O et al. Evolution and significance of circulating procalcitonin levels compared with IL- 6, TNF-alpha and endotoxin levels early after thermal injury. Burns. 1997 May;23(3):218-24. PubMed | Google Scholar

  10. Simon A, Bijzet J, Voorbij HA, Mantovani A et al. Effect of inflammatory attacks in the classical type hyper-IgD syndrome on immunoglobulin D, cholesterol and parameters of the acute phase response. Intern Med. 2004 Sep;256(3):247-53. PubMed | Google Scholar

  11. Patout M, Salaün M, Brunel V, Bota S et al. Diagnostic and prognostic value of serum procalcitonin concentrations in primary lung cancers. Clinical Biochemistry. 2014 Dec;47(18): 263-7. PubMed | Google Scholar